Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/12/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval
Pfizer Inc. (NYSE: PFE) Delayed: 27.72 +0.07 (0.25%)
Previous Close $27.65    52 Week High $37.39 
Open $27.80    52 Week Low $28.25 
Day High $27.85    P/E 16.80 
Day Low $27.42    EPS $1.65 
Volume 25,551,822       

Pfizer Inc. (NYSE: PFE) Delayed: 27.72 +0.07 (0.25%)
Previous Close $27.65    52 Week High $37.39 
Open $27.80    52 Week Low $28.25 
Day High $27.85    P/E 16.80 
Day Low $27.42    EPS $1.65 
Volume 25,551,822